Effects of fingolimod in relapsing-remitting multiple sclerosis

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning

Standard

Effects of fingolimod in relapsing-remitting multiple sclerosis. / Sorensen, Per Soelberg.

I: Lancet Neurology, Bind 13, Nr. 6, 06.2014, s. 526-527.

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning

Harvard

Sorensen, PS 2014, 'Effects of fingolimod in relapsing-remitting multiple sclerosis', Lancet Neurology, bind 13, nr. 6, s. 526-527. https://doi.org/10.1016/S1474-4422(14)70067-5

APA

Sorensen, P. S. (2014). Effects of fingolimod in relapsing-remitting multiple sclerosis. Lancet Neurology, 13(6), 526-527. https://doi.org/10.1016/S1474-4422(14)70067-5

Vancouver

Sorensen PS. Effects of fingolimod in relapsing-remitting multiple sclerosis. Lancet Neurology. 2014 jun.;13(6):526-527. https://doi.org/10.1016/S1474-4422(14)70067-5

Author

Sorensen, Per Soelberg. / Effects of fingolimod in relapsing-remitting multiple sclerosis. I: Lancet Neurology. 2014 ; Bind 13, Nr. 6. s. 526-527.

Bibtex

@article{1d3b32aa6089455aa2588eceb6e15588,
title = "Effects of fingolimod in relapsing-remitting multiple sclerosis",
keywords = "Clinical Trials as Topic, Humans, Immunosuppressive Agents, Multiple Sclerosis, Relapsing-Remitting, Propylene Glycols, Sphingosine, Treatment Outcome",
author = "Sorensen, {Per Soelberg}",
year = "2014",
month = jun,
doi = "10.1016/S1474-4422(14)70067-5",
language = "English",
volume = "13",
pages = "526--527",
journal = "The Lancet Neurology",
issn = "1474-4422",
publisher = "TheLancet Publishing Group",
number = "6",

}

RIS

TY - JOUR

T1 - Effects of fingolimod in relapsing-remitting multiple sclerosis

AU - Sorensen, Per Soelberg

PY - 2014/6

Y1 - 2014/6

KW - Clinical Trials as Topic

KW - Humans

KW - Immunosuppressive Agents

KW - Multiple Sclerosis, Relapsing-Remitting

KW - Propylene Glycols

KW - Sphingosine

KW - Treatment Outcome

U2 - 10.1016/S1474-4422(14)70067-5

DO - 10.1016/S1474-4422(14)70067-5

M3 - Comment/debate

C2 - 24685277

VL - 13

SP - 526

EP - 527

JO - The Lancet Neurology

JF - The Lancet Neurology

SN - 1474-4422

IS - 6

ER -

ID: 138616870